bibliographicCitation |
Casciano R, Chulikavit M, Di Lorenzo G, Liu Z, Baladi JF, Wang X, Robertson J, Garrison L. Economic evaluation of everolimus versus sorafenib for the treatment of metastatic renal cell carcinoma after failure of first-line sunitinib. Value Health. 2011 Sep;14(6):846–51. doi: 10.1016/j.jval.2011.04.008. PMID: 21914504. |